During the next few years, over a dozen middle-income countries are likely to transition away from multilateral concessional assistance—that is, grants and loans that offer flexible or lenient terms for repayment—including support from International Development Association (IDA) and Gavi, the Vaccine Alliance. There are good reasons to worry these countries, including Nigeria and Pakistan, will … Read More
News
Find the latest news related to achieving sustainable and equitable immunisation programmes, as well as the archive of past Linked newsletter issues.
Results 231 - 240 of 238
Updated Template for Key Messages on ‘Why Investing in Immunization is a Priority’
New data on the equity impact of lives saved and medical impoverishment averted from immunization has been included in the template of key messages. Get the updated slidedeck template here, and access the original article here.
TVEE Publishes Open Source Health Economics Courses on OpenCourseWare
The Teaching Vaccine Economics Everywhere (TVEE) project is pleased to announce that three modules from its vaccine economics curriculum are now available to the public for free on the JHSPH OpenCourseWare (OCW). The modules published are Health Economics for Vaccines, Costing in Vaccine Planning and Programming, and Economic Evaluation and are available here. Anybody can … Read More
The Equity Impact Vaccines May Have On Averting Deaths And Medical Impoverishment In Developing Countries
A team of researchers modeled the equity impact of lives saved and medical impoverishment averted from immunization over the period 2016-30 in 41 low and middle income countries (DHS survey availability determined which countries were selected for inclusion). Of our 15 LNCT member countries, data from Armenia, Ghana, Indonesia, Nigeria, and Timor-Leste were included in … Read More
New Rotavirus Vaccine Prequalified by WHO
Bharat Biotech announced that ROTAVAC® has achieved pre-qualification by the World Health Organization (WHO), making it available for procurement by United Nations agencies and GAVI, the Vaccine Alliance, for use in low-resource countries. ROTAVAC is substantially cheaper than current rotavirus vaccines on the global market and will be available at $1/dose. Read more about ROTAVAC’s … Read More
LNCT Welcomes Curatio
The Curatio International Foundation (CIF) has joined the Learning Network for Countries in Transition as a regional partner based in Tbilisi, Georgia. Curatio brings a thorough understanding of the financial and programmatic aspects of immunization programs, expertise in health systems, financing and policy, and extensive experience on transition and sustainability of Gavi supported programs. Curatio will work … Read More
New Guide Helps Countries Assess Immunization Financing Options
Helen Saxenian, Cheryl Cashin, and Paul Wilson, Results for Development Maintaining high rates of immunization coverage, which is essential for a persistent reduction in the incidence of vaccine-preventable infectious diseases, requires a sufficient and sustained investment. In order to ensure that governments are making adequate investments in immunization financing and are doing so through sustainable … Read More
Return on Investment from Immunization
Sachiko Ozawa, Samantha Clark, Allison Portnoy, Simrun Grewal, Logan Brenzel, and Damian G. Walker An important research article was published in Health Affairs in February 2016, quantifying the “return on investment” from investments in immunization. The analysis covered 94 low and middle income countries, including all 73 Gavi countries. It uses projected coverage rates for … Read More